The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
Official Title: A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
Study ID: NCT00423644
Brief Summary: The study of safety of a new organic arsenic compound in the treatment of advanced multiple myeloma
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Glendale, Arizona, United States
, Santa Barbara, California, United States
, Santa Rosa, California, United States
, West Hollywood, California, United States
, Bethesda, Maryland, United States
, Buffalo, New York, United States
, Charlotte, North Carolina, United States
, Sioux Falls, South Dakota, United States